[Federal Register Volume 70, Number 2 (Tuesday, January 4, 2005)]
[Notices]
[Page 391]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-77]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 1, 2004, Houba, Inc., 
PO Box 190, 16235 State Road 17, Culver, Indiana 46511, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in Schedule II; and by letter dated October 1, 2004, 
to modify its name to Acura Pharmaceutical Technologies, Inc., and 
change the address by removing the P.O. Box 190.

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration pursuant to 21 CFR 
1301.33(a).
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative, 
Office of Liaison and Policy (ODLR) and must be filed no later than 
March 7, 2005.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-77 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P